Terms: = Ovarian cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Diagnosis
32 results:
1. Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2-AS2/MEK/erk/STAT3 signaling.
Ling L; Wen Y; Xiong Y; Liu X; Chen J; Liu T; Zhang B
J Gene Med; 2024 Jan; 26(1):e3571. PubMed ID: 37483091
[TBL] [Abstract] [Full Text] [Related]
2. High-grade Serous Carcinoma can Show Squamoid Morphology Mimicking True Squamous Differentiation.
Tomonobe H; Ohishi Y; Hachisuga K; Yahata H; Kato K; Oda Y
Am J Surg Pathol; 2023 Sep; 47(9):967-976. PubMed ID: 37382102
[TBL] [Abstract] [Full Text] [Related]
3. Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-κB and TGF-β2 signaling.
Lin SC; Liao YC; Chen PM; Yang YY; Wang YH; Tung SL; Chuang CM; Sung YW; Jang TH; Chuang SE; Wang LH
J Biomed Sci; 2022 Dec; 29(1):109. PubMed ID: 36550569
[TBL] [Abstract] [Full Text] [Related]
4. Optimized Transcriptional Signature for Evaluation of MEK/erk Pathway Baseline Activity and Long-Term Modulations in ovarian cancer.
Chesnokov MS; Yadav A; Chefetz I
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362153
[TBL] [Abstract] [Full Text] [Related]
5. miRNA-651-3p regulates EMT in ovarian cancer cells by targeting ZNF703 and via the MEK/erk pathway.
Wang S; Wang C; Liu O; Hu Y; Li X; Lin B
Biochem Biophys Res Commun; 2022 Sep; 619():76-83. PubMed ID: 35749939
[TBL] [Abstract] [Full Text] [Related]
6. The Role of Long Non-Coding RNA CCAT1 and SNHG14 in Activation of Some Protein-Coding Genes Associated with the Development of ovarian cancer.
Brovkina OI; Pronina IV; Burdennyy AM; Uroshlev LA; Filippova EA; Fridman MV; Kazubskaya TP; Zhordania KI; Loginov VI; Kushlinskii NE; Braga EA
Bull Exp Biol Med; 2022 Apr; 172(6):760-764. PubMed ID: 35501644
[TBL] [Abstract] [Full Text] [Related]
7. Human Epididymis Protein 4 and Lewis y Enhance Chemotherapeutic Resistance in Epithelial ovarian cancer Through the p38 MAPK Pathway.
Gao J; Zhu L; Zhuang H; Lin B
Adv Ther; 2022 Jan; 39(1):360-378. PubMed ID: 34739698
[TBL] [Abstract] [Full Text] [Related]
8. Dysfunction of miR-802 in tumors.
Gao T; Zou M; Shen T; Duan S
J Clin Lab Anal; 2021 Nov; 35(11):e23989. PubMed ID: 34558723
[TBL] [Abstract] [Full Text] [Related]
9. Large ovarian tumors in adolescents, a systematic review of reported cases, diagnostic findings and surgical management.
Grigore M; Murarasu M; Himiniuc LM; Toma BF; Duma O; Popovici R
Taiwan J Obstet Gynecol; 2021 Jul; 60(4):602-608. PubMed ID: 34247795
[TBL] [Abstract] [Full Text] [Related]
10. NUT Carcinoma in the Pelvic Cavity With Unusual Pathologic Features.
Jung M; Kim SI; Kim JW; Jeon YK; Lee C
Int J Gynecol Pathol; 2022 May; 41(3):292-297. PubMed ID: 34166280
[TBL] [Abstract] [Full Text] [Related]
11. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing mapk1 expression by serving as the sponge of miR-21-5p.
Li Y; Qin J; He Z; Cui G; Zhang K; Wu B
Genes Genomics; 2021 Feb; 43(2):141-150. PubMed ID: 33481227
[TBL] [Abstract] [Full Text] [Related]
12. Flavonoids Restore Platinum Drug Sensitivity to ovarian Carcinoma Cells in a Phospho-erk1/2-Dependent Fashion.
Koren Carmi Y; Mahmoud H; Khamaisi H; Adawi R; Gopas J; Mahajna J
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906729
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of cell blocks from effusion specimens in Gynecologic Oncopathology: An experience of 220 cases, diagnosed at a Tertiary cancer Referral Center.
Rekhi B; Karmarkar S; Gupta C; Deodhar KK; Menon S; Pathuthara S; Maheshwari A; Shylasree TS; Gupta S
Indian J Pathol Microbiol; 2020; 63(3):427-434. PubMed ID: 32769333
[TBL] [Abstract] [Full Text] [Related]
14. Multifunctional APJ Pathway Promotes ovarian cancer Progression and Metastasis.
Neelakantan D; Dogra S; Devapatla B; Jaiprasart P; Mukashyaka MC; Janknecht R; Dwivedi SKD; Bhattacharya R; Husain S; Ding K; Woo S
Mol Cancer Res; 2019 Jun; 17(6):1378-1390. PubMed ID: 30858172
[TBL] [Abstract] [Full Text] [Related]
15. PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma.
Ma H; Li Y; Wang X; Wu H; Qi G; Li R; Yang N; Gao M; Yan S; Yuan C; Kong B
Cell Death Dis; 2019 Feb; 10(3):166. PubMed ID: 30778048
[TBL] [Abstract] [Full Text] [Related]
16. Polyunsaturated fatty acids induce ovarian cancer cell death through ROS-dependent MAP kinase activation.
Tanaka A; Yamamoto A; Murota K; Tsujiuchi T; Iwamori M; Fukushima N
Biochem Biophys Res Commun; 2017 Nov; 493(1):468-473. PubMed ID: 28882592
[TBL] [Abstract] [Full Text] [Related]
17. RNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective.
Gov E; Kori M; Arga KY
Syst Biol Reprod Med; 2017 Aug; 63(4):219-238. PubMed ID: 28574782
[TBL] [Abstract] [Full Text] [Related]
18. High-yield of biologically active recombinant human fibroblast growth factor-16 in E. coli and its mechanism of proliferation in NCL-H460 cells.
Cheng J; Fang Z; Yang H; Li Y; Tian H; Gong W; Chen T; Liu M; Li X; Jiang C
Prep Biochem Biotechnol; 2017 Aug; 47(7):720-729. PubMed ID: 28409700
[TBL] [Abstract] [Full Text] [Related]
19. Axl molecular targeting counteracts aggressiveness but not platinum-resistance of ovarian carcinoma cells.
Corno C; Gatti L; Arrighetti N; Carenini N; Zaffaroni N; Lanzi C; Perego P
Biochem Pharmacol; 2017 Jul; 136():40-50. PubMed ID: 28404378
[TBL] [Abstract] [Full Text] [Related]
20. Conserved insulin signaling in the regulation of oocyte growth, development, and maturation.
Das D; Arur S
Mol Reprod Dev; 2017 Jun; 84(6):444-459. PubMed ID: 28379636
[TBL] [Abstract] [Full Text] [Related]
[Next]
